Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cannabidiol Treatment in Patients With Early Psychosis

NCT02504151 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT02504151
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02504151 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cannabidiol Treatment in Patients With Early Psychosis
Lead sponsor
Yale University
Phase
Phase 2
Overall status
Completed
Start date
January 28, 2016
Completion date
March 9, 2018
Enrollment
18 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

schizoaffective disorder, schizophrenia